Prospective, multi-centre, non-interventional safety study to collect real-world data on the safety of immunotherapy with Depigoid® Katze in patients with allergic rhinitis/rhino-conjunctivitis with or without controlled asthma due to feline epithelia (LETI MIAU-KAT 2022)

04/03/2022
22/05/2025
EU PAS number:
EUPAS46091
Study
Finalised
Documents
Study protocol
Study results
Study results
English (377.29 KB - PDF) View document
Study report
Study report
English (1.66 MB - PDF) View document
English (5.75 MB - PDF) View document
Other information
Study, other information
English (227.56 KB - PDF) View document
English (53.46 KB - PDF) View document
English (89.97 KB - PDF) View document